Share
 
Title
Code
Session Type
Track
Format
CME accreditation
ROOM/CHANNEL
Date Time
Moderators

While individual therapeutic modalities (such as therapeutic vaccination, broadly neutralizing antibody or bNAb infusion, inhibition of immunosuppressive pathways, potentiation of immunostimulatory pathways and HIV latency reversal agents) are being explored for their capacity to induce control of HIV, mounting evidence suggests that durable remission of HIV may require a combination of agents. This session will highlight different strategies for combining therapeutic modalities to achieve antiretroviral-free remission of HIV.

14:15
2 min
Introduction
Thumbi NDUNG'U, Africa Health Research Institute, University of KwaZulu-Natal, South Africa
Katherine J. BAR, Penn Centre for AIDS Research, United States
14:17
15 min
Combination therapies with bNAbs
Marina CASKEY, The Rockefeller University, United States
14:32
15 min
Combinations to reprogramme CD8+ T cells
Asier SAEZ-CIRION, Institut Pasteur, France
14:47
15 min
Combination therapies in non-human primates
Afam OKOYE, Oregon Health and Science University, United States
15:02
13 min
Q&A
Thumbi NDUNG'U, Africa Health Research Institute, University of KwaZulu-Natal, South Africa
Asier SAEZ-CIRION, Institut Pasteur, France
Afam OKOYE, Oregon Health and Science University, United States
Marina CASKEY, The Rockefeller University, United States
Katherine J. BAR, Penn Centre for AIDS Research, United States
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT